Psychiatry · Sugar Land, TX
NPI
1659575231
Since 2007
Specialty
Psychiatry
Code 2084P0800X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3531 Town Center Blvd S, Suite # 101
Sugar Land, TX, 77479
Phone (409) 457-7213
Groups this clinician bills Medicare through
Medicare paid, 2024
$138K
2,142 services
Medicare patients, 2024
51
Average age 54
Drug cost, 2024
$1.6M
3,489 prescriptions
Company payments, 2025
$2,352
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gabriella R Pasztor was code 99232 (hospital e&m - subsequent), 1,960 times for 45 patients. In total Gabriella R Pasztor billed 2,142 services in 5 codes, and Medicare paid $138K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-11-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,960 | 45 | $62.82 | $123K |
| 99238 Hospital Discharge Management | Facility | 38 | 33 | $64.54 | $2,453 |
| 99222 Hospital E&M - Initial | Facility | 30 | 23 | $100.74 | $3,022 |
| 99223 Hospital E&M - Initial | Facility | 19 | 17 | $126.52 | $2,404 |
By year: 2022 $211K for 3,585 services; 2023 $122K for 1,874 services; 2024 $138K for 2,142 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gabriella R Pasztor prescribed most often to Medicare patients was Quetiapine Fumarate, with 241 prescriptions and refills. In total Gabriella R Pasztor wrote 3,489 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Quetiapine Fumarate Generic | 241 | 243 | 36 | $3,248 |
| Trazodone Hcl Generic | 214 | 216 | 42 | $1,821 |
| Benztropine Mesylate Generic | 198 | 202 | 35 | $2,212 |
| Divalproex Sodium Er Divalproex Sodium | 192 | 192 | 37 | $4,577 |
| Desvenlafaxine Succinate Er Desvenlafaxine Succinate | 149 | 149 | 33 | $7,366 |
| Risperidone Generic | 123 | 123 | 19 | $1,090 |
| Invega Sustenna Paliperidone Palmitate | 120 | 120 | 37 | $409K |
| Mirtazapine Generic | 106 | 106 | 18 | $952 |
| Ziprasidone Hcl Generic | 97 | 97 | 15 | $4,722 |
| Buspirone Hcl Generic | 95 | 95 | 18 | $1,287 |
| Sertraline Hcl Generic | 91 | 91 | 16 | $351 |
| Olanzapine Odt Olanzapine | 88 | 88 | 23 | $7,922 |
| Paliperidone Er Paliperidone | 84 | 84 | 17 | $22K |
| Oxcarbazepine Generic | 82 | 90 | 17 | $3,079 |
| Clonazepam Generic | 82 | 82 | 20 | $700 |
Brand drugs: - claims; generic drugs: 3,106 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gabriella R Pasztor $2,352 ($2,352 in general payments such as food, travel and fees) from 10 companies. The largest payer was Neurocrine BioSciences, Inc. with $754.
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. NBIX | 30 | $754 |
| Teva Pharmaceuticals USA, Inc. TEVA | 23 | $499 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 16 | $391 |
| E.R. Squibb & Sons, L.L.C. BMY | 14 | $293 |
| Luye Pharma (USA) Ltd. 2186.HK | 13 | $165 |
| Alkermes, Inc. ALKS | 5 | $124 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $57.98 |
| Janssen Pharmaceuticals, Inc JNJ | 2 | $29.82 |
| Noven Therapeutics, LLC | 1 | $20.4 |
| Vanda Pharmaceuticals Inc. VNDA | 1 | $17 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.